<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on April 16, 2026 at 11:58 am by All in One SEO v4.9.5.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://thepharmacanada.ca/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>The PharmaCanada</title>
		<link><![CDATA[https://thepharmacanada.ca]]></link>
		<description><![CDATA[The PharmaCanada]]></description>
		<lastBuildDate><![CDATA[Tue, 31 Jul 2018 08:50:32 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://thepharmacanada.ca/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://thepharmacanada.ca/categories-v2/]]></guid>
			<link><![CDATA[https://thepharmacanada.ca/categories-v2/]]></link>
			<title>Categories v2</title>
			<pubDate><![CDATA[Tue, 31 Jul 2018 08:50:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://thepharmacanada.ca/users/]]></guid>
			<link><![CDATA[https://thepharmacanada.ca/users/]]></link>
			<title>Users</title>
			<pubDate><![CDATA[Tue, 17 Jan 2017 15:37:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://thepharmacanada.ca/trend/]]></guid>
			<link><![CDATA[https://thepharmacanada.ca/trend/]]></link>
			<title>Trend</title>
			<pubDate><![CDATA[Tue, 17 Jan 2017 15:37:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://thepharmacanada.ca/hot/]]></guid>
			<link><![CDATA[https://thepharmacanada.ca/hot/]]></link>
			<title>Explore</title>
			<pubDate><![CDATA[Tue, 17 Jan 2017 15:36:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://thepharmacanada.ca/health-canada-approves-cysklar-cysteamine-ophthalmic-solution-for-cystinosis-related-corneal-crystals/]]></guid>
			<link><![CDATA[https://thepharmacanada.ca/health-canada-approves-cysklar-cysteamine-ophthalmic-solution-for-cystinosis-related-corneal-crystals/]]></link>
			<title>Health Canada approves Cysklar (cysteamine ophthalmic solution) for cystinosis-related corneal crystals</title>
			<pubDate><![CDATA[Thu, 16 Apr 2026 09:58:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://thepharmacanada.ca/health-canada-clears-cta-for-aftx-201-in-bag3-dcm-to-be-evaluated-in-phase-1-2-upbeat-trial/]]></guid>
			<link><![CDATA[https://thepharmacanada.ca/health-canada-clears-cta-for-aftx-201-in-bag3-dcm-to-be-evaluated-in-phase-1-2-upbeat-trial/]]></link>
			<title>Health Canada clears CTA for AFTX-201 in BAG3 DCM, to be evaluated in Phase 1/2 UPBEAT trial</title>
			<pubDate><![CDATA[Thu, 16 Apr 2026 07:54:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://thepharmacanada.ca/health-canada-approves-denoza-a-biosimilar-to-prolia-denosumab/]]></guid>
			<link><![CDATA[https://thepharmacanada.ca/health-canada-approves-denoza-a-biosimilar-to-prolia-denosumab/]]></link>
			<title>Health Canada approves Denoza, a biosimilar to Prolia (denosumab)</title>
			<pubDate><![CDATA[Thu, 16 Apr 2026 07:53:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://thepharmacanada.ca/health-canada-grants-noc-to-saphnelo-anifrolumab-sc-autoinjector-for-sle/]]></guid>
			<link><![CDATA[https://thepharmacanada.ca/health-canada-grants-noc-to-saphnelo-anifrolumab-sc-autoinjector-for-sle/]]></link>
			<title>Health Canada grants NOC to Saphnelo (anifrolumab) SC autoinjector for SLE</title>
			<pubDate><![CDATA[Thu, 16 Apr 2026 07:52:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://thepharmacanada.ca/health-canada-approves-empaveli-pegcetacoplan-for-c3g-ic-mpgn/]]></guid>
			<link><![CDATA[https://thepharmacanada.ca/health-canada-approves-empaveli-pegcetacoplan-for-c3g-ic-mpgn/]]></link>
			<title>Health Canada approves Empaveli (pegcetacoplan) for C3G/IC-MPGN</title>
			<pubDate><![CDATA[Thu, 16 Apr 2026 06:17:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://thepharmacanada.ca/reactions/]]></guid>
			<link><![CDATA[https://thepharmacanada.ca/reactions/]]></link>
			<title>Reactions</title>
			<pubDate><![CDATA[Sat, 29 Apr 2017 09:08:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://thepharmacanada.ca/nsfw/]]></guid>
			<link><![CDATA[https://thepharmacanada.ca/nsfw/]]></link>
			<title>NSFW</title>
			<pubDate><![CDATA[Mon, 30 Jan 2017 21:50:24 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://thepharmacanada.ca/categories/]]></guid>
			<link><![CDATA[https://thepharmacanada.ca/categories/]]></link>
			<title>Categories</title>
			<pubDate><![CDATA[Mon, 30 Jan 2017 21:48:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://thepharmacanada.ca/users-v2/]]></guid>
			<link><![CDATA[https://thepharmacanada.ca/users-v2/]]></link>
			<title>Users v2</title>
			<pubDate><![CDATA[Fri, 07 Jun 2019 18:24:28 +0000]]></pubDate>
		</item>
				</channel>
</rss>
